Skip to main content
Premium Trial:

Request an Annual Quote

Diagenode and MIT Researchers Partner to Automate ChIP-seq Experiments

Premium

The David H. Koch Institute for Integrative Cancer Research and the BioMicro Center at the Massachusetts Institute of Technology are collaborating with Diagenode to automate assays for ChIP-seq and methyl-seq experiments.

The MIT researchers conducted "extensive tests" of Diagenode's SX-8G IP-Star system to validate its use in automating the design of epigenetic assays and next-gen sequencing library preparation. They are also using the system as a quality control for screening antibodies for ChIP-seq experiments.

Robert Urban, executive director of the Koch Institute, said in a statement that being able to automate customizable epigenetic assay design will support the "growing experimental needs of our oncology research community." In addition, Diagenode's SX-8G IP-Star system has "simplified the quality control of ChIP upfront of our ChIP-seq experiments."

The Scan

US Booster Eligibility Decision

The US CDC director recommends that people at high risk of developing COVID-19 due to their jobs also be eligible for COVID-19 boosters, in addition to those 65 years old and older or with underlying medical conditions.

Arizona Bill Before Judge

The Arizona Daily Star reports that a judge weighing whether a new Arizona law restricting abortion due to genetic conditions is a ban or a restriction.

Additional Genes

Wales is rolling out new genetic testing service for cancer patients, according to BBC News.

Science Papers Examine State of Human Genomic Research, Single-Cell Protein Quantification

In Science this week: a number of editorials and policy reports discuss advances in human genomic research, and more.